SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-020257
Filing Date
2022-05-16
Accepted
2022-05-16 08:30:52
Documents
48
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fbrx-10q_20220331.htm   iXBRL 10-Q 1576104
2 EX-31.1 fbrx-ex311_8.htm EX-31.1 20782
3 EX-31.2 fbrx-ex312_9.htm EX-31.2 20785
4 EX-32.1 fbrx-ex321_6.htm EX-32.1 8880
5 EX-32.2 fbrx-ex322_7.htm EX-32.2 8925
  Complete submission text file 0001564590-22-020257.txt   4947302

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA fbrx-20220331.xsd EX-101.SCH 34228
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbrx-20220331_cal.xml EX-101.CAL 22423
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbrx-20220331_def.xml EX-101.DEF 104902
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbrx-20220331_lab.xml EX-101.LAB 298104
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbrx-20220331_pre.xml EX-101.PRE 211217
42 EXTRACTED XBRL INSTANCE DOCUMENT fbrx-10q_20220331_htm.xml XML 691505
Mailing Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502
Business Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38052 | Film No.: 22925715
SIC: 2834 Pharmaceutical Preparations